Am Heart J

1. WHITE HD, O'Brien SM, Boden WE, Fremes SE, et al
   Use of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention and Associated Outcomes in the ISCHEMIA Trial.
   Am Heart J. 2025 May 20:S0002-8703(25)00165-6. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   
2. MESSINGER MC, Ashburn NP, Chait JS, Snavely AC, et al
   Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States.
   Am Heart J. 2025 May 13:S0002-8703(25)00157-7. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   

   
   Ann Thorac Surg

3. PARK SJ, Park TH, Kim Y, Kim S, et al
   2514 Cases of Thoracoabdominal and Descending Thoracic Aorta Surgery: Strategies Associated With Improved Survival, Stroke, and Paraplegia.
   Ann Thorac Surg. 2025;120:312-320.
   

   >> Share

   
   
4. NORMAN AV, Weber MP, El Moheb M, Wisniewski AM, et al
   Ideal Timing of Coronary Artery Bypass Grafting after Non-ST Elevation Myocardial Infarction.
   Ann Thorac Surg. 2025 Feb 11:S0003-4975(25)00113.
   

   >> Share

   
   

   
   Eur Heart J

5. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
   Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
   Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
   

   >> Share

   
   

   
   Heart

6. PARKER WAE
   Evolution of coronary stents: innovations, antithrombotic strategies and future directions.
   Heart. 2025 Mar 4:heartjnl-2024-324744. doi: 10.1136/heartjnl-2024-324744.
   

   >> Share

   
   
7. SANCHIS J, Bueno H, Marti Sanchez D, Martinez-Selles M, et al
   Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial.
   Heart. 2025 Feb 8:heartjnl-2024-325254. doi: 10.1136/heartjnl-2024-325254.
   

   >> Share

   
   

   
   J Thorac Cardiovasc Surg

8. ROCHA RV, Yau TM, Chu A, Lee DS, et al
   Do Non-fatal MACCE In The First 5-years Post CABG Affect 10-year Outcomes?
   J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00841.
   

   >> Share

   
   
9. KIM H, Lee OJ, Lee JH, Kim YJ, et al
   Impact of the Grade and Jet-flow Direction of Residual Aortic Regurgitation after Valve-Sparing Root Replacement.
   J Thorac Cardiovasc Surg. 2024 Sep 24:S0022-5223(24)00840.
   

   >> Share

   
   
10. OUCHI T, Kato N, Kato H, Higashigawa T, et al
    Scoring system to predict mid-term adverse events after elective thoracic endovascular aortic repair.
    J Thorac Cardiovasc Surg. 2025;170:437-444.
    

    >> Share

    
    
11. RAM E, Lau C, Dimagli A, Harik L, et al
    Reoperative Aortic Root Replacement Following Previous Cardiac Surgery or Type A Aortic Dissection Repair.
    J Thorac Cardiovasc Surg. 2024 Aug 24:S0022-5223(24)00767.
    

    >> Share

    
    
12. KAWCZYNSKI MJ, Gabrio A, Maessen JG, van 't Hof AWJ, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary bypass surgery for coronary artery disease: a Bayesian perspective.
    J Thorac Cardiovasc Surg. 2024 Aug 20:S0022-5223(24)00701.
    

    >> Share

    
    
13. IMAMURA Y, Takayama Y, Kowatari R, Minakawa M, et al
    Reverse cannulation method as a strategy for aortic aneurysm surgery: A computational fluid dynamics study on minimizing neurological risks.
    J Thorac Cardiovasc Surg. 2025;170:456-464.
    

    >> Share

    
    

    
    J Vasc Interv Radiol

14. YANG Z, Li Y, Chen H, Bao H, et al
    Comparison of the Effectiveness of Inguinal Lymphangiography and Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhosis-Related Chylous Ascites.
    J Vasc Interv Radiol. 2025;36:1341-1346.
    

    >> Share

    
    
15. MERAM E, Monroe EJ, McKernan M, Woods MA, et al
    Portal Venous Decompression for Treatment of Portal Hypertension-Related Refractory Chylous Ascites or Chylothorax.
    J Vasc Interv Radiol. 2025;36:1336-1340.
    

    >> Share

    
    
16. NADEEM IM, Rahman Y, Nadeem L, Manokaran T, et al
    The Effectiveness of Metanephrine-Based Compared with Cortisol-Based Measurements to Assess Selectivity and Lateralization of Adrenal Vein Sampling in Primary Aldosteronism: A Systematic Review.
    J Vasc Interv Radiol. 2025;36:1268-1277.
    

    >> Share

    
    
17. TIE J, Liu L, Yuan X, Niu J, et al
    Transjugular Splenocaval Shunt Creation for the Treatment of Portal Vein Cavernous Transformation with Recurrent Variceal Hemorrhage.
    J Vasc Interv Radiol. 2025;36:1330-1335.
    

    >> Share

    
    
18. ASHRAF N, Chaiah Y, Arabi TZ, Venkatakrishnan A, et al
    Safety and Effectiveness of Sharp Recanalization for Thoracic Central Venous Occlusion: A Systematic Review and Pooled Analysis.
    J Vasc Interv Radiol. 2025;36:1254-1267.
    

    >> Share

    
    
19. PARK J, Bang S, Han K, Kwon JH, et al
    Safety and Patency of Bare-Metal Stent versus Stent Graft Placement in Patients with Extrahepatic Portal Vein Occlusion from Pancreatic and Biliary Malignancies.
    J Vasc Interv Radiol. 2025;36:1321-1329.
    

    >> Share

    
    
20. KNOTT E, Kapoor B, Chansangrat J, Partovi S, et al
    Single-Center Experience of Portal Vein Recanalization and Transjugular Intrahepatic Shunt Placement in Patients with Portovisceral Thrombosis.
    J Vasc Interv Radiol. 2025;36:1313-1320.
    

    >> Share

    
    

    
    PLoS Med

21. SU X, Qiu M, Gu C, Yang X, et al
    Analysis of inter-hospital transfer on clinical outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A secondary analysis of the BRIGHT-4 trial.
    PLoS Med. 2025;22:e1004679.
    

    >> Share

    
    

    
    PLoS One

22. KANG M, Zhao Y, Meng Y, Ma Q, et al
    Endovascular repair of type B acute aortic syndromes involving the left subclavian artery: A retrospective single-centre study.
    PLoS One. 2025;20:e0328817.
    

    >> Share

    
    

    
    Stroke

23. MENZIES LE, Aziz YN, Adeoye O, Broderick JP, et al
    Adjunctive Antithrombotic Medications to Acute Reperfusion Therapy: Current Evidence and Future Directions.
    Stroke. 2025;56:2369-2374.
    

    >> Share

    
    
24. CHOWDHURY SS, Wiebe K, James G, Abruzzo T, et al
    Exploring the Ethical Landscape of Pediatric Neuroendovascular Treatments.
    Stroke. 2025;56:2360-2368.
    

    >> Share

    
    
25. MAKIMOTO H, Sasabuchi Y, Kabutoya T, Kohro T, et al
    Preventive Effects of Prasugrel on Cerebrovascular Events Following Percutaneous Coronary Intervention.
    Stroke. 2025 May 23. doi: 10.1161/STROKEAHA.125.050366.
    

    >> Share

    
    
26. WOUTERS A, Demeestere J, Rossel JB, Devroye A, et al
    Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN Trial.
    Stroke. 2025 May 22. doi: 10.1161/STROKEAHA.125.050646.
    

    >> Share

    
    
27. PAUILLAC N, Faille D, Solo Nomenjanahary M, Souvanheuane M, et al
    Fibrinogen Depletion Coagulopathy and Hemorrhagic Transformation in Acute Ischemic Stroke Treated With Bridging Therapy.
    Stroke. 2025 May 21. doi: 10.1161/STROKEAHA.125.051230.
    

    >> Share

    
    
28. NGUYEN TN, Dabus G, McGuinness B, Caldwell J, et al
    SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thrombectomy.
    Stroke. 2025 May 21. doi: 10.1161/STROKEAHA.125.051742.
    

    >> Share

    
    
29. SUN D, Guo X, Ling L, Jiao L, et al
    Sex-Related Differences in Endovascular Treatment Outcomes for Acute Large Infarcts: The ANGEL-ASPECT Subanalysis.
    Stroke. 2025 May 9. doi: 10.1161/STROKEAHA.124.050025.
    

    >> Share

    
    
30. XU Y, Xiao L, Zhang P, Shi W, et al
    One-Year Outcome After Endovascular Thrombectomy for Basilar Artery Occlusion With Mild Deficits.
    Stroke. 2025 Apr 25. doi: 10.1161/STROKEAHA.124.050389.
    

    >> Share

    
    
31. VOS EM, Peeters-Scholte CMPCD, Boiten J, Hund HM, et al
    Safety, Tolerability, and Pharmacokinetics of the Neuroprotectant 2-Iminobiotin in Patients With Large-Vessel Occlusion Ischemic Stroke Treated With Endovascular Thrombectomy.
    Stroke. 2025 Apr 24. doi: 10.1161/STROKEAHA.125.050560.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share